Antibiotic resistance of Gardnerella vaginalis isolated from cases of becterial vaginosis;Lekowrażliwość szczepów Gardnerella vaginalis wyizolowanych z przypadków bakteryjnej waginozy

Ginekologia Polska

Volumn 82, Issue 12, 2011, Pages 900-904

  Tomusiak, Anna ^a   Strus, Magdalena ^a   Heczko, Piotr Bogumił ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Antibiotic susceptibility; Bacterial vaginosis; Gardnerella vaginalis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CLINDAMYCIN; METRONIDAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; GARDNERELLA VAGINALIS; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; POLAND; VAGINA; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADULT; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-INFECTIVE AGENTS; BACTERIAL TYPING TECHNIQUES; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; FEMALE; GARDNERELLA VAGINALIS; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLAND; VAGINA; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 84859382450     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Romanik M, Ekiel A, Tomana L, Martirosian G. Waginoza bakteryjna - problemy terapii. Wiad Lek. 2007, 60, 64-66.
2. Livengood C. Bacterial vaginosis: an overview for 2009. Rev Obstet Gynecol. 2009, 2, 28-37.
3. Drzewiecki A, Strus M, Heczko P. Bakteryjna waginoza i zapalenie pochwy wywołane przez bakterie tlenowe. Diagnostyka i leczenie. Med Prakt Ginek. 2005, 6, 34.
4. Joesoef M, Wiknjosastro G, Norojono W, [et al.]. Coinfection with chlamydia and gonorrhoea among pregnant women with bacterial vaginosis. Int J STD AIDS. 1996, 7, 61-64.
5. Martin H, Richardson B, Nyange P, [et al.]. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis. 1999, 180, 1863-1868.
6. Romanik M, Martirosian G. Cze{ogonek}stość wyste{ogonek}powania, kryteria diagnostyczne i naste{ogonek}pstwa bakteryjnego zakażenia pochwy u kobiet cie{ogonek}żarnych. Przegl Epidemiol. 2004, 58, 547-553.
7. Hay P, Lamont R, Taylor-Robinson D, [et al.]. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ. 1994, 308, 295-298.
8. Greaves W, Chungafung J, Morris B, [et al.]. Clindamycin versus metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol. 1988, 72, 799-802.
9. Ferris D, Litaker M, Woodward L, [et al.]. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel and clindamycin vaginal cream. J Fam Pract. 1995, 41, 443-449.
10. Austin M, Beigi R, Meyn L, Hillier A.. Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J Clin Microbiol. 2005, 43, 4492-4497.
11. Sobel J, Schmitt C, Meriweather C. Long term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. J Infect Dis. 1993, 167, 783-784.